Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity

被引:0
作者
V. Calabrese
G. Scapagnini
A. M. Giuffrida Stella
T. E. Bates
J. B. Clark
机构
[1] University of Catania,Section of Biochemistry and Molecular Biology, Department of Chemistry, Faculty of Medicine
[2] University College London,Department of Neurochemistry, Institute of Neurology
来源
Neurochemical Research | 2001年 / 26卷
关键词
Oxidative stress; mitochondrial diseases; energy thresholds; caloric restriction; vitagenes;
D O I
暂无
中图分类号
学科分类号
摘要
It is becoming increasingly evident that the mitochondrial genome may play a key role in neurodegenerative diseases. Mitochondrial dysfunction is characteristic of several neurodegenerative disorders, and evidence for mitochondria being a site of damage in neurodegenerative disorders is partially based on decreases in respiratory chain complex activities in Parkinson's disease, Alzheimer's disease, and Huntington's disease. Such defects in respiratory complex activities, possibly associated with oxidant/antioxidant balance perturbation, are thought to underlie defects in energy metabolism and induce cellular degeneration. Efficient functioning of maintenance and repair process seems to be crucial for both survival and physical quality of life. This is accomplished by a complex network of the so-called longevity assurance processes, which are composed of genes termed vitagenes. A promising approach for the identification of critical gerontogenic processes is represented by the hormesis-like positive effect of stress. In the present review, we discuss the role of energy thresholds in brain mitochondria and their implications in neurodegeneration. We then review the evidence for the role of oxidative stress in modulating the effects of mitochondrial DNA mutations on brain age-related disorders and also discuss new approaches for investigating the mechanisms of lifetime survival and longevity.
引用
收藏
页码:739 / 764
页数:25
相关论文
共 768 条
  • [91] Malgat M.(2001)Nitric oxide and nitric oxide synthase in Huntington's disease J. Neurosci. Res. 64 99-107
  • [92] Rocher C.(2000)Heat shock and the control of the stress response Biochem. Pharmacol. 59 55-63
  • [93] Faustin B.(2000)Reduced glutathione oxidation ratio and 8-OHdG accumulation by mild ischemic pretreatment Brain Res. 856 28-36
  • [94] Letellier T.(1999)Inhibitors of mitochondrial respiration, iron (II) and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: Potential implications to Parkinson's disease J. Neurochem. 73 1683-1695
  • [95] Letellier T.(1994)Spin trapping of azidyl and hydroxyl radicals in azide-inhibited submitochondrial particles Arch. Biochem. Biophys. 310 210-217
  • [96] Malgat M.(1997)Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions Brain Res. 765 183-188
  • [97] Rossignol R.(1992)Cytochrome oxidase inhibition: A novel animal model of Alzheimer's disease J. Geriatr. Psychiatry Neurol. 5 93-101
  • [98] Mazat J. P.(2001)Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro J. Neurochem. 76 1050-1056
  • [99] Davey G. P.(1999)beta-Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria FEBS Lett. 457 131-134
  • [100] Peuchen S.(1999)Mitotic signaling by beta-amyloid causes neuronal death FASEB J. 13 2225-2234